Skip to content
Open access

Modeling antibody recognition across SARS-CoV-2 and SARS-CoV-1 using epitope-informed transfer learning

Aug 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 18 references
Medicine

TL;DR

Existing immunological datasets can support feature-constrained transfer learning for data-efficient prioritization of antibody:antigen interactions across closely related Sarbecoviruses, particularly when conserved epitope regions can be aligned and limited target-specific measurements are available for calibration.

Abstract

Antiviral antibody discovery is constrained by the enormous combinatorial space of antibody paratopes and viral epitopes, while novel approaches to search for these vast possibilities such as machine learning models for antibody affinity prediction typically require large target-specific datasets that are rarely available for emerging pathogens. To address this problem, we investigated the ability of transfer learning to reduce the required training data and still create a robust predictive model of antibody affinities. We show that antibody-affinity prediction can be locally transferred from a data-rich viral target to a related data-limited viral target by combining transfer learning, epitope-centered antigen encoding, antibody CDR descriptors, and targeted experimental validation. Using SARS-CoV-2 receptor-binding-domain (RBD) interaction data as the source domain, we developed dual-encoder neural-network models that capture functional determinants of antibody recognition and supports prediction of SARS-CoV-1 variant:antibody affinities despite limited direct training data. High-throughput ELISA measurements generated compact validation datasets spanning heavy-chain-only antibodies (HCAbs) and conventional antibodies, enabling iterative model refinement through similarity-guided, model-informed data expansion. Across expanded withheld-antibody evaluations, the final models showed improved but antibody-dependent predictive performance, with mean Pearson correlations of 0.71 ± 0.12 for SARS-CoV-2 and 0.63 ± 0.09 for SARS-CoV-1, and best-performing holdouts reaching 0.85 and 0.78, respectively. These results demonstrate that existing immunological datasets can support feature-constrained transfer learning for data-efficient prioritization of antibody:antigen interactions across closely related Sarbecoviruses, particularly when conserved epitope regions can be aligned and limited target-specific measurements are available for calibration.

Read PDF

Similar papers

Open access Jul 2026

Deep learning-based prediction of drug-target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach.

This study applies MPS2IT-DTI (Molecule and Protein Sequence to Image Transformer for Drug-Target Interaction), a deep learning framework that represents molecular and protein sequences as images as images using k-mer frequency encoding, enabling convolutional neural networks to capture spatial compositional patterns a...

J. D. de Souza, M. Fernandes, Raquel de Melo Barbosa · 0 citations
Jul 2026

Experimental Validation of Variant Antibodies Guided by a Large Language Model and Optimized through Combinatorial Algorithms 2307181

This study integrates large language model-guided antibody design with experimental validation to assess the real-world performance of computationally optimized antibodies, and will clarify how effectively AI-generated sequences translate into functional high-affinity binders, informing the development of future therap...

Sanaz Zebardast, F. Ashraf, Zihao Zhang et al. · 0 citations
Open access Jul 2026

Structural and functional dissection of neutralisation differences among SARS-CoV-2 variants using antigenicity prediction and CR3022 binding analysis

A combined experimental and computational characterization of SARS-CoV-2 variant-specific neutralisation across infection, vaccination and hybrid immunity-driven cohorts is provided, offering a hypothesis-generating framework to contextualize observed differences in antibody responses and epitope recognition across var...

Jyoti Sawant, Ajit Patil, Madhuri Thakar et al. · 0 citations
Open access Aug 2026

Structural and mutational analyses define distinct molecular routes to broad SARS-CoV-2 receptor-binding domain recognition

Two human-derived monoclonal antibodies are characterized that recognize conserved epitopes on the SARS-CoV-2 RBD and retain activity across antigenically distinct variants, and conserved, mutationally constrained epitopes may serve as targets for vaccines designed to elicit antibody responses resilient to ongoing SARS...

M. Abernathy, William B. Foreman, Jasmyn A. Lopez et al. · 0 citations
Open access Aug 2026

Mimic antibodies: leveraging ligand mimicry for epitope-targeted antibody discovery

The concept of mimic antibodies–antibodies that recapitulate the binding mode of a target’s cognate ligand is investigated and established as a promising strategy for rational antibody selection, engineering, and design, with broad implications for therapeutic antibody development and drug discovery.

Brennan Abanades, Joanan López-Morales, Ivana Tanasijević et al. · 2 citations
Open access Jul 2026

Benchmarking AlphaFold and related deep learning approaches for modeling antibody and TCR antigen recognition

It is shown that increased sampling and AlphaFold3 generally improve performance relative to default sampling and AlphaFold2, however predictive accuracy and improvement levels varied considerably among interface classes, with antibody-peptide complexes representing a challenge despite their small antigen size.

Rui Yin, S. Saravanakumar, S. Shi et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.